SAGILITY LIMITED (SAGILITY)
Small CapIT stocks · Small cap · NSE
Sagility Limited (formerly Sagility India Limited) is an IT company providing healthcare operations, clinical services, and AI-led transformation capabilities. It focuses on strengthening its position in healthcare quality, especially for Medicare Advantage plans, through differentiated analytics and HEDIS capabilities.
One read, four checks
75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.
Weak fundamentals, while price trend supports entry. This looks more like momentum/speculation than a clean fundamental investment setup.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
low confidence · 0/0 claims checked
Timing lens: price trend and sector relative strength.
Rolling lens: recent quarterly delivery, not the latest single-result score.
Quarter ended 30 Jun 2026
Good · 67/100Rev +28% YoY · PAT +46% YoY · operating leverage · margin compression
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,963 Cr | +27.6% | -3.0% |
| EBITDA | ₹438 Cr | +26.6% | -9.7% |
| Operating margin | 22.0% | +0 bps | -200 bps |
| PAT | ₹217 Cr | +45.6% | -15.9% |
| PAT margin | 11.1% | +137 bps | -170 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Business & thesis
Growth engines, tailwinds/headwinds, and risk radar from management commentary
Where growth can come from, and what can break the case
Q1 FY27 saw strong 27.6% YoY revenue growth (15.2% CC) and 35.1% YoY Adjusted PAT growth, driven by existing client expansion and new wins. Adjusted EBITDA margin remained steady at 24.0% YoY, but declined QoQ due to seasonal revenue absence and wage hikes.
Sagility delivered robust Q1 FY27 results with strong organic growth and a strategic acquisition (CareSeed) enhancing its healthcare quality offerings. While margins held YoY, QoQ decline and wage hike impact warrant monitoring. Client concentration remains high, but diversification efforts are visible.
Revenue by Vertical Split
Latest issuer-disclosed distribution across 2 reported categories.
Organic Growth
27.3% Y-o-Y organic growth in Q1 FY27, driven by expansion within existing clients and rising contribution from FY26 new client wins.
Strategic Acquisitions
Acquired CareSeed to strengthen position in healthcare quality, adding analytics and HEDIS capabilities, expanding platform depth and mid-market reach with 26 new clients.
New Client Wins
Won $35.3M of steady state ACV in Q1 FY27, driven by expansion opportunities / new SOWs across 18 existing clients and 1 new logo.
AI and Domain-led Operations
Independent research validates healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model.
Healthcare Market Demand
Independent research validates the healthcare market trends driving demand for Sagility’s AI and domain-led healthcare operations model.
Payer Shift to Strategic Partners
Payer expectations are shifting toward strategic partners, valuing understanding of the complete payer ecosystem and commitment to outcomes.
Minimum Wage Hikes
Increases in statutory minimum wages in Karnataka and Telangana, effective May 22 and June 1, 2026, respectively.
Forex Loss
Q1 FY27 Forex loss of ₹283M was driven by foreign exchange hedges.
Client Concentration
Top 3 clients contribute 60.1% of TTM Jun'26 revenues, indicating high reliance on a few large clients.
Wage Inflation
Statutory minimum wage hikes in Karnataka and Telangana are estimated to have a ~1.2% margin impact on revenues for FY27.
Management accountability
What management said, and what results must prove
Management accountability
What management said, and what results must prove
What management said, and what results must prove
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is crucial for assessing long-term growth and the impact of strategic initiatives like acquisitions. QoQ is important to understand sequential momentum, the impact of seasonal revenue absence, and the immediate effects of cost pressures like wage hikes.
Revenue from Operation (YoY%)
Q1 FY27 Revenue from Operation (in ₹ M) 19,635, YoY growth 27.6% (15.2% in CC).
Adjusted EBITDA %
Q1 FY27 Adjusted EBITDA % 24.0%.
Adjusted PAT %
Q1 FY27 Adjusted PAT % 13.7%.
Voluntary attrition rate (%)
Q1 FY27 Voluntary attrition rate^ (%) 28.6%.
Debt Repayment
Debt to be fully repaid in current Financial year (FY27).
CareSeed Integration
Combining CareSeed’s technology with Sagility’s healthcare operations, clinical services, and AI-led transformation capabilities to deliver an end-to-end quality operations continuum.
Focus on Quality Operations
Strengthens Sagility's position in Quality for Medicare Advantage (MA) - expanding capabilities across HEDIS, CMS Stars, quality reporting, and care-gap orchestration.
Numbers and claims to verify in the next filings
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Adjusted EBITDA Margin | 24.0% (Q1 FY27) | Sustained margin levels despite wage hikes and seasonal revenue absence. |
| Steady State ACV Wins | $35.3M (Q1 FY27) | Continued strong deal wins from existing clients and new logos to drive future growth. |
| Client Concentration (Top 3) | 60.1% (TTM Jun'26) | Diversification of revenue base and reduction in reliance on top clients. |
| Debt Repayment | ₹5,670M (Closing Debt FY26) | Full repayment of debt in FY27 as planned. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trend score and candlestick chart
65BullishSMA20 +3.2% / mo · MACD +
Technical chart
SAGILITYdaily · 1Y · AUTO+17.8%Daily technical trend read
NeutralTrend is undirectional — long-term uptrend intact. RSI 69.
- Price above SMA200 (long-term uptrend) but mid-term MAs not aligned.
- SMA20 rising (~3.1% over last month) — short-term momentum positive.
- RSI(14) at 69 — sideways, no extreme reading.
- MACD above signal but histogram contracting — bullish momentum cooling.
- 19% off 52W high · 31% above 52W low.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Relative Strength & Trend Stage
- 14.2% below the 52-week closing high after prior strength.
- The 30-week proxy has stalled (-2.1% over 20 sessions).
- Price has not yet confirmed a full Stage 4 downtrend.
Valuation & score drivers
U-Score 38 · WATCHLIST · pillar breakdown, sector model, fair-value anchor
Valuation & score drivers
U-Score 38 · WATCHLIST · pillar breakdown, sector model, fair-value anchor
Fundamental score breakdown
WATCHLISTWhy this score?
Top U-Score contributors and drags from the latest stored fundamentals.
Positive drivers
- Piotroski is strong at 8/9.
- Cash flow contributes 8/10 to the score.
- Balance sheet contributes 9/15 to the score.
Main drags
- Fair-value margin of safety is negative at -56.7%.
- Valuation is weaker at 3/30; verify the latest quarterly trend.
- Quality is weaker at 4/20; verify the latest quarterly trend.
Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Score history
12 stored score snapshots. Latest stored move: +2 points.
Factor attribution
Modelled fair value
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust score
Does management behaviour match later outcomes? Claim delivery, forensic breakdown, evidence depth
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Healthy Trust: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 85th percentile within IT. No major sub-score weakness stands out.
High Trust Lite: Promoter pledge is zero. Key concern: Promoter holding fell 16.4%.
Generally investable credibility. Look for weak sub-scores before increasing position size.
overall median 67 · IT: 85th pctile, median 69 · Small: 91st pctile, median 66
48 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Healthy Trust · low confidenceRead Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust positives
- ▸Promoter pledge is zero.
- ▸FCF yield is positive at 2.4%.
- ▸4 years of positive FCF.
- ▸4/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸Promoter holding fell 16.4%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Financials
Full fundamentals table and 10-year revenue / profit / ROE history
Fundamentals
Valuation
- P/E
- 21.30
- P/B
- 2.27
- EV/EBITDA
- 9.82
- Market Cap
- 21918.00Cr
Profitability
- ROE
- 10.60%
- ROCE
- 13.40%
- ROA
- 7.98%
- Dividend Y
- 0.32%
Growth (CAGR)
- Revenue 5Y
- 6.00%
- EPS 5Y
- 6.00%
- Revenue 3Y
- 19.00%
- EPS 3Y
- 86.00%
Balance Sheet
- Debt/Equity
- 0.12
- Interest Coverage
- 19.67×
- Altman Z
- 6.65
- Book Value
- 20.60
Cash Flow
- FCF Yield
- 2.35%
- FCF Positive Y
- 4/5
- OCF
- 1203.00 Cr
- EPS TTM
- 2.12
Shareholding
- Promoter Hold
- 50.95%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 50%
Financial History
Updated 5/9/2026
Revenue
₹ CrNet Profit
₹ CrReturn on Equity
%Peers
Business-comparable names in IT, ranked by similarity
Peers
Business-comparable names in IT, ranked by similarity
Peers
Business-comparable peers in IT — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.